Renal function impacts outcomes after intestinal transplantation

Transplantation

Volumn 86, Issue 1, 2008, Pages 117-122

  Watson, Melissa J ^a   Venick, Robert S ^a   Kaldas, Fady ^b   Rastogi, Anjay ^a   Gordon, Sherilyn A ^a   Colangelo, Joanna ^a   Esmailian, Yvonne ^a   McDiarmid, Sue V ^a   Busuttil, Ronald W ^a   Farmer, Douglas G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Intestinal transplantation; Outcomes; Renal function

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; IMMUNOTHERAPY; INTENSIVE CARE UNIT; INTESTINE TRANSPLANTATION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTOR VARIABLE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL TIME; INTENSIVE CARE; INTESTINE; KAPLAN MEIER METHOD; KIDNEY; KIDNEY DISEASE; MORTALITY; ORGAN TRANSPLANTATION; PATHOPHYSIOLOGY; STATISTICAL MODEL; TIME; TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; CHILD; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTENSIVE CARE; INTESTINES; KAPLAN-MEIERS ESTIMATE; KIDNEY; KIDNEY DISEASES; LOGISTIC MODELS; MALE; ORGAN TRANSPLANTATION; RETROSPECTIVE STUDIES; RISK FACTORS; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 49849098988     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31817d55ae     Document Type: Article

References (22)

1. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after Transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931.
2. Fraley DS, Burr R, Bernardini J, et al. Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation. Kidney Int 1998; 54: 518.
3. Gonwa TA, Mai ML, Melton LB, et al. End-stage renal disease (ESRD) after orthotopic liver Transplantation (OLTX) using calcineurin-based immunotherapy: Risk of development and treatment. Transplantation 2001; 72: 1934.
4. Rubel JR, Milford EL, McKay DB, et al. Renal insufficiency and endstage renal disease in the heart transplant population. J Heart Lung Transplant 2004; 23: 289.
5. Rocha PN, Rocha AT, Palmer SM, et al. Acute renal failure after lung transplantation: Incidence, predictors and impact on perioperative morbidity and mortality. Am J Transplant 2005; 5: 1469.
6. Lin LY, Lin HC, Lee PC, et al. Hyperglycemia correlates with outcomes in patients receiving total parenteral nutrition. Am J Med Sci 2007; 333: 261.
7. Llop JM, Muñoz C, Bad́ia MB, et al. Serum albumin as indicator of clinical evolution in patients on parenteral nutrition. Multivariate study. Clin Nutr 2001; 20: 77.
8. Kato T, Tzakis AG, Selvaggi G, et al. Intestinal and multivisceral transplantation in children. Ann Surg 2006; 243: 756.
9. Ueno T, Kato T, Gaynor J, et al. Renal dysfunction following adult intestinal transplant under tacrolimus-based immunosuppression. Transplant Proc 2006; 38: 1762.
10. Kaldas F, Farmer D, Gordon SA, et al. Renal event outcomes in intestinal transplantation: results from a single-center experience. Transplant Proc 2007; 39: 3387.
11. Buchman A, Moukarzel A, Ament M, et al. Serious renal impairment is associated with long-term parenteral nutrition. JPEN 1993; 17: 438.
12. Venick RS, Gordon SA, McDiarmid SV, et al. Renal failure is a predictor of wait-list mortality for candidates with intestinal failure awaiting organ transplantation. World Transplant Congress 2006 oral symposium presentation. Am J Transplant 2006; (WTC suppl): 282.
13. Yalavarthy R, Edelstein CL, Teitelbaum I. Acute renal failure and chronic kidney disease following liver transplantation. Hemodial Int 2007; 11: S7.
14. Delgado DH, Miriuka SG, Cusimano RJ, et al. Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunction. J Heart Lung Transplant 2005; 24: 166.
15. Lee CK, Christensen LL, Magee JC, et al. Pre-transplant risk factors for chronic renal dysfunction after pediatric heart transplantation: A 10-year national cohort study. J Heart Lung Transplant 2007; 26: 458.
16. McDiarmid SV. Renal function in pediatric liver transplant patients. Kidney Int Suppl 1996; 53: S77.
17. Sachdeva R, Blaszak RT, Ainley KA, et al. Determinants of renal function in pediatric heart transplant recipients: Long-term follow-up study. J Heart Lung Transplant 2007; 26: 108.
18. Hmiel SP, Beck AM, de la Morena MT, et al. Progressive chronic kidney disease after pediatric lung transplantation. Am J Transplant 2005; 5: 1739.
19. UenoT,Kato T, Gaynor J, et al. Renal function after pediatric intestinal transplant. Transplant Proc 2006; 38: 1759.
20. Campbell KM, Yazigi N, Ryckman FC, et al. High prevalence of renal dysfunction in long-term survivors after pediatric liver transplantation. J Pediatr 2006; 148: 475.
21. Ibrahim HN, Rogers T, Tello A, et al. The performance of three serum creatinine-based formulas in estimating GFR in former kidney donors. Am J Transplant 2006; 6: 1479.
22. Mattman A, Eintracht S,MockT,et al. Estimating pediatric glomerular filtration rates in the era of chronic kidney disease staging. J Am Soc Nephrol 2006; 17: 487.